Search Results

Search Results for "risperdal"

• PA Supreme Court May Renew Risperdal Lawsuits Facing Statute of Limitations Challenges
  From the moment you sustain an injury or are harmed by a drug, corporation, or other entity, a clock starts ticking. Like a shot clock in a basketball game, this clock limits the amount of time you have to act on your injury before the law says you can no longer take action. This time period is call...

• For Some Risperdal Users, Side Effect Reminder is as Close as Nearest Mirror
  Former users of Janssen Pharmaceuticals’ antipsychotic drug Risperdal continue to feel the impact of a long-undisclosed potential side effect of the medication. The drug is intended to treat schizophrenia and bipolar disorder, however, since its release, multiple misrepresentations about Risperdal...

• Judge Shocks Both Sides with Move to Dismiss Risperdal Case
  Most of the time, a judge’s actions in a case are somewhat expected by at least one side. A plaintiff or defendant might argue for a particular action and the outcome is based on either the success or failure of that argument. However, every so often a judge does something that catches both sides ...

• J&J to Pay $7.8 Million in Arkansas Risperdal Lawsuit
  Pharmaceutical giant Johnson & Johnson has agreed to pay $7.8 million to settle a seven-and-a-half-year-old Risperdal lawsuit, the Arkansas Democrat-Gazette reports. The state of Arkansas filed the lawsuit in 2007, alleging that Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, unl...

• Former FDA Commissioner May Testify Against Johnson & Johnson in Risperdal Lawsuit
  Ongoing litigation against the pharmaceutical giant Johnson & Johnson (J&J) involves the allegations of improper and deceitful marketing of their antipsychotic drug, Risperdal. A Risperdal lawsuit being heard in the Philadelphia Common Pleas Court may take an interesting turn with the invo...

• Johnson & Johnson Guilty Plea Helps Risperdal Lawsuits
  After a ten-year long criminal investigation, Johnson & Johnson has entered a guilty plea and will pay $2.2 billion in damages. The U.S. Department of Justice charged the company with promoting the drugs Risperdal and Invega for off-label uses (uses that were not approved by the FDA). These dru...

• J&J settles Risperdal lawsuit on first day of trial
  On the first day of trial, Johnson & Johnson settled a lawsuit centering on complaints that its antipsychotic drug Risperdal caused a male plaintiff to grow breasts, Bloomberg reports. The terms of the settlement are confidential. It was the first of about 130 lawsuits alleging that Risperdal ca...

• Feds want to question new J&J CEO in Risperdal fraud case
  In a motion filed as part of a fraud case against Johnson & Johnson, the federal government alleges that new company CEO Alex Gorsky “was actively involved in matters at issue in this case,” Forbes reports. Government prosecutors charge that Johnson & Johnson paid kickbacks to Omnicare, ...

• Blog: $1.2b J&J fine for Risperdal deceptive marketing likely to cause further problems
  A post on stock market information Website Seeking Alpha says Johnson & Johnson will likely deal with significant public backlash going forward. An Arkansas jury recently concluded that the company used deceptive tactics to market antipsychotic drug Risperdal, which included hiding or minimizing...

• Jury says Johnson & Johnson improperly marketed Risperdal
  A jury in Arkansas ruled that Johnson & Johnson officials used deceptive tactics to market antipsychotic drug Risperdal, misleading doctors about the drug’s risks and improperly marketing it for unapproved uses, Bloomberg reports. The decision in Arkansas marks the third such jury verdict agai...